Alterations of striatal NMDA receptor subunits associated with the development of dyskinesia in the MPTP-lesioned primate model of Parkinson's disease

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961 · see citing works

Glutamate receptor ion channels

Mayer, M. L. (2005) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2005.05.004 · Cited by 3,645 · see citing works

Domain Interaction Between NMDA Receptor Subunits and the Postsynaptic Density Protein PSD-95

Kornau, H., Schenker, L. T., Kennedy, M. B., & Seeburg, P. H. (1995) · Science · doi:10.1126/science.7569905 · Cited by 1,882 · see citing works

Frequency of levodopa‐related dyskinesias and motor fluctuations as estimated from the cumulative literature

Ahlskog, J. E., & Muenter, M. D. (2001) · Movement Disorders · doi:10.1002/mds.1090 · Cited by 1,456 · see citing works

Modification of Parkinsonism — Chronic Treatment with L-Dopa

Cotzias, G. C., Papavasiliou, P. S., & Gellene, R. A. (1969) · New England Journal of Medicine · doi:10.1056/nejm196902132800701 · Cited by 1,287 · see citing works

Syntaxin: A Synaptic Protein Implicated in Docking of Synaptic Vesicles at Presynaptic Active Zones

Bennett, M. K., Calakos, N., & Scheller, R. H. (1992) · Science · doi:10.1126/science.1321498 · Cited by 1,263 · see citing works

Changing subunit composition of heteromeric NMDA receptors during development of rat cortex

Sheng, M., Cummings, J., Roldan, L. A., Jan, Y. N., & Jan, L. Y. (1994) · Nature · doi:10.1038/368144a0 · Cited by 1,170 · see citing works

The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurones

Smith, A. D., & Bolam, J. P. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90106-k · Cited by 1,040 · see citing works

Synaptic organisation of the basal ganglia

Bolam, J. P., Hanley, J. J., Booth, P. A. C., & Bevan, M. D. (2000) · Journal of Anatomy · doi:10.1046/j.1469-7580.2000.19640527.x · Cited by 950 · see citing works

Pathophysiology of levodopa-induced dyskinesia: Potential for new therapies

Bézard, E., Brotchie, J., & Gross, C. (2001) · Nature Reviews Neuroscience · doi:10.1038/35086062 · Cited by 518 · see citing works

Relationship between the Appearance of Symptoms and the Level of Nigrostriatal Degeneration in a Progressive 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Lesioned Macaque Model of Parkinson's Disease

Bézard, E., Doveró, S., Prunier, C., Ravenscroft, P., Chalon, S., Guilloteau, D., Crossman, A. R., Bioulac, B. H., Brotchie, J. M., & Gross, C. E. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-17-06853.2001 · Cited by 484 · see citing works

Modulatory functions of neurotransmitters in the striatum: ACh/dopamine/NMDA interactions

Di Chiara, G., Morelli, M., & Consolo, S. (1994) · Trends in Neurosciences · doi:10.1016/0166-2236(94)90005-1 · Cited by 467 · see citing works

The majority of N-methyl-D-aspartate receptor complexes in adult rat cerebral cortex contain at least three different subunits (NR1/NR2A/NR2B).

Luo, J.-H., Wang, Y.-H., Yasuda, R., Dunah, A., & Wolfe, B. (1997) · Molecular Pharmacology · doi:10.1124/mol.51.1.79 · Cited by 427 · see citing works

Long‐term Potentiation in the Striatum is Unmasked by Removing the Voltage‐dependent Magnesium Block of NMDA Receptor Channels

Calabresi, P., Pisani, A., Mercuri, N. B., & Bernardi, G. (1992) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1992.tb00119.x · Cited by 418 · see citing works

Dopamine D1 Receptor-Dependent Trafficking of Striatal NMDA Glutamate Receptors to the Postsynaptic Membrane

Dunah, A. W., & Standaert, D. G. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-15-05546.2001 · Cited by 374 · see citing works

Organization of N‐methyl‐D‐aspartate glutamate receptor gene expression in the basal ganglia of the rat

Standaert, D. G., Testa, C. M., Young, A. B., & Penney, J. B. (1994) · The Journal of Comparative Neurology · doi:10.1002/cne.903430102 · Cited by 370 · see citing works

Levodopa‐induced dyskinesias improved by a glutamate antagonist in parkinsonia monkeys

Papa, S. M., & Chase, T. N. (1996) · Annals of Neurology · doi:10.1002/ana.410390505 · Cited by 292 · see citing works

Differential Tyrosine Phosphorylation of N-Methyl-D-aspartate Receptor Subunits

Lau, L., & Huganir, R. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.34.20036 · Cited by 276 · see citing works

Alterations in Subunit Expression, Composition, and Phosphorylation of Striatal N-Methyl-d-Aspartate Glutamate Receptors in a Rat 6-Hydroxydopamine Model of Parkinson’s Disease

Dunah, A. W., Wang, Y., Yasuda, R. P., Kameyama, K., Huganir, R. L., Wolfe, B. B., & Standaert, D. G. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)23206-5 · Cited by 262 · see citing works

Striatal dopamine- and glutamate-mediated dysregulation in experimental parkinsonism

Chase, T. N., & Oh, J. D. (2000) · Trends in Neurosciences · doi:10.1016/s1471-1931(00)00018-5 · Cited by 250 · see citing works

Parkinson Disease, the Effect of Levodopa, and the ELLDOPA Trial

Fahn, S. (1999) · Archives of Neurology · doi:10.1001/archneur.56.5.529 · Cited by 246 · see citing works

Immunohistochemical localization of metabotropic glutamate receptors mGluR1a and mGluR2/3 in the rat basal ganglia

Testa, C. M., Friberg, I. K., Weiss, S. W., & Standaert, D. G. (1998) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19980105)390:1 · Cited by 237 · see citing works

Rationale for and use of NMDA receptor antagonists in Parkinson's disease

Hallett, P. J., & Standaert, D. G. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.04.001 · Cited by 236 · see citing works

Levodopa-induced motor complications are associated with alterations of glutamate receptors in Parkinson's disease

Calon, F., Rajput, A. H., Hornykiewicz, O., Bédard, P. J., & Paolo, T. D. (2003) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.07.003 · Cited by 221 · see citing works

Interaction with newly synthesized and retained proteins in the endoplasmic reticulum suggests a chaperone function for human integral membrane protein IP90 (calnexin)

David, V., Hochstenbach, F., Rajagopalan, S., & Brenner, M. B. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98391-2 · Cited by 207 · see citing works

Dopamine D1-Dependent Trafficking of Striatal N-Methyl-d-aspartate Glutamate Receptors Requires Fyn Protein Tyrosine Kinase but Not DARPP-32

Dunah, A. W., Sirianni, A. C., Fienberg, A. A., Bastia, E., Schwarzschild, M. A., & Standaert, D. G. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.1.121 · Cited by 175 · see citing works

Striatal mechanisms and pathogenesis of parkinsonian signs and motor complications.

Chase, T. N., & Oh, J. D. (2000) · PubMed · Cited by 164 · see citing works

Differing Effects of N-methyl-d-aspartate Receptor Subtype Selective Antagonists on Dyskinesias in Levodopa-Treated 1-Methyl-4-phenyl-tetrahydropyridine Monkeys

Blanchet, P. J., Konitsiotis, S., Whittemore, E. R., Zhou, Z., Woodward, R. M., & Chase, T. N. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35003-7 · Cited by 158 · see citing works

Abnormal Ca2+-Calmodulin-Dependent Protein Kinase II Function Mediates Synaptic and Motor Deficits in Experimental Parkinsonism

Picconi, B. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.1224-04.2004 · Cited by 156 · see citing works

Enhanced tyrosine phosphorylation of striatal NMDA receptor subunits: effect of dopaminergic denervation and l-DOPA administration

Oh, J. D., Russell, D., Vaughan, C. L., & Chase, T. N. (1998) · Brain Research · doi:10.1016/s0006-8993(98)01049-x · Cited by 151 · see citing works

Effect of a selective glutamate antagonist on l-dopa-induced dyskinesias in drug-naive parkinsonian monkeys

Tahar, A. H., Grégoire, L., Dare, A., Bélanger, N., Meltzer, L. T., & Bédard, P. J. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.10.007 · Cited by 141 · see citing works

Expression of NMDA glutamate receptor subunit mRNAs in neurochemically identified projection and interneurons in the striatum of the rat

Standaert, D. G., Friberg, I. K., Landwehrmeyer, G. B., Young, A. B., & Penney, J. B. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00293-9 · Cited by 141 · see citing works

Toward an understanding of the role of glutamate in experimental parkinsonism: Agonist‐sensitive sites in the basal ganglia

Klockgether, T., & Turski, L. (1993) · Annals of Neurology · doi:10.1002/ana.410340413 · Cited by 140 · see citing works

Antiparkinsonian Actions of CP-101,606, an Antagonist of NR2B Subunit-Containing N-Methyl-d-Aspartate Receptors

Steece‐Collier, K., Chambers, L. K., Jaw‐Tsai, S., Menniti, F. S., & Greenamyre, J. T. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7374 · Cited by 138 · see citing works

Dopamine/glutamate interactions in Parkinson's disease

Lange, K. W., Kornhuber, J., & Riederer, P. F. (1997) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(96)00043-7 · Cited by 131 · see citing works

Antiparkinsonian Actions of Ifenprodil in the MPTP-Lesioned Marmoset Model of Parkinson's Disease

Nash, J. E., Fox, S. H., Henry, B., Hill, M. P., Peggs, D., McGuire, S., Maneuf, Y. P., Hille, C. J., Brotchie, J. M., & Crossman, A. R. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7444 · Cited by 127 · see citing works

Effect of dopamine denervation and dopamine agonist administration on serine phosphorylation of striatal nmda receptor subunits

Oh, J. D., Vaughan, C. L., & Chase, T. N. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01121-x · Cited by 121 · see citing works

The MPTP-treated primate as a model of motor complications in PD

Jenner, P. G. (2003) · Neurology · doi:10.1212/wnl.61.6_suppl_3.s4 · Cited by 109 · see citing works

Expression of NMDA receptor subunit mRNAs in neurochemically identified projection and interneurons in the human striatum

K�ppenbender, K. D., Standaert, D. G., Feuerstein, T. J., Penney, J. B., Young, A. B., & Landwehrmeyer, G. B. (2000) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(20000417)419:4 · Cited by 104 · see citing works

Antiparkinsonian activity of Ro 25-6981, a NR2B subunit specific NMDA receptor antagonist, in animal models of Parkinson's disease

Löschmann, P. A., de Groote, C., Smith, L. A., Wüllner, U., Fischer, G., Kemp, J. A., Jenner, P. G., & Klockgether, T. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.01.018 · Cited by 101 · see citing works

Alteration of glutamate receptors in the striatum of dyskinetic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys following dopamine agonist treatment

Calon, F., Morissette, M., Ghribi, O., Goulet, M., Grondin, R., Blanchet, P. J., Bédard, P. J., & Paolo, T. D. (2002) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(01)00237-8 · Cited by 93 · see citing works

Tyrosine phosphorylation of NMDA receptor in rat striatum: effects of 6-OH-dopamine lesions

Menegoz, M., Lau, L., Hervé, D., et al. (1995) · Neuroreport · doi:10.1097/00001756-199512290-00030 · Cited by 93 · see citing works

Subcellular segregation of distinct heteromeric NMDA glutamate receptors in the striatum

Dunah, A. W., & Standaert, D. G. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01744.x · Cited by 89 · see citing works

NR2B selective NMDA receptor antagonist CP-101,606 prevents levodopa-induced motor response alterations in hemi-parkinsonian rats

Wessell, R., Ahmed, S. M., Menniti, F. S., Dunbar, G. L., Chase, T. N., & Oh, J. D. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.03.011 · Cited by 84 · see citing works

Antiparkinsonian Actions of Blockade of NR2B-Containing NMDA Receptors in the Reserpine-Treated Rat

Nash, J. E., Hill, M. P., & Brotchie, J. M. (1999) · Experimental Neurology · doi:10.1006/exnr.1998.6963 · Cited by 80 · see citing works

Exploration of the Dopamine Transporter: In Vitro and In Vivo Characterization of a High-Affinity and High-Specificity Iodinated Tropane Derivative (E)-N-(3-iodoprop-2-enyl)-2β-carbomethoxy- 3β-(4′-methylphenyl)nortropane (PE2I)

Guilloteau, D., Emond, P., Baulieu, J., et al. (1998) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(97)00224-2 · Cited by 72 · see citing works

Differential expression and ser897 phosphorylation of striatal N -methyl- d -aspartate receptor subunit NR1 in animal models of Parkinson's disease

Betarbet, R. S., Poisik, O. V., Sherer, T., & Greenamyre, J. T. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2003.12.012 · Cited by 35 · see citing works

Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies

Dalmau, J., Gleichman, A. J., Hughes, E. G., Rossi, J. E., Peng, X., Lai, M., Dessain, S. K., Rosenfeld, M. R., Balice-Gordon, R., & Lynch, D. R. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70224-2 · Cited by 3,488 · see citing works

NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease

Paoletti, P., Bellone, C., & Zhou, Q. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3504 · Cited by 2,523 · see citing works

The serotonergic system in Parkinson's disease

Huot, P., Fox, S. H., & Brotchie, J. M. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.08.004 · Cited by 195 · see citing works

Effects of a NR2B selective NMDA glutamate antagonist, CP‐101,606, on dyskinesia and parkinsonism

Nutt, J. G., Gunzler, S. A., Kirchhoff, T., Hogarth, P., Weaver, J. L., Krams, M., Jamerson, B., Menniti, F. S., & Landen, J. W. (2008) · Movement Disorders · doi:10.1002/mds.22169 · Cited by 133 · see citing works

Serotonin–dopamine interaction in the induction and maintenance of l-DOPA-induced dyskinesias

CARTA, M., CARLSSON, T., MUNOZ, A., KIRIK, D., & BJORKLUND, A. (2008) · Progress in brain research · doi:10.1016/s0079-6123(08)00922-9 · Cited by 131 · see citing works

Psychiatric Manifestations of Paraneoplastic Disorders

Kayser, M. S., Kohler, C. G., & Dalmau, J. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.09101547 · Cited by 129 · see citing works

MADOPAR-INDUCED DYSKINESIA IN 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP) HEMIPARKINSONIAN MONKEY MODEL

陈生弟, 周孝达, 钱可久, et al. (1991) · 上海交通大学学报：医学英文版

Suppressive effect of FK-506, a novel immunosuppressant, against MPTP-induced dopamine depletion in the striatum of young C57BL/6 mice

Kitamura, Y., Itano, Y., Kubo, T., & Nomura, Y. (1994) · Journal of Neuroimmunology · doi:10.1016/0165-5728(94)90049-3 · Cited by 96 · see citing works

~(125)I-IBZM autoradiographic study of striatal dopamine D_2 receptor activity in MPTP-induced mouse model of Parkinson's disease

Liu, Z. (2000) · Shanghai yixue

Stereotaxic injection of GD1a ganglioside induces limited recovery of striatal dopaminergic system in MPTP‐treated aging mice

Date, I., Notter, M. F. D., Felten, S. Y., et al. (1991) · Journal of Neuroscience Research · doi:10.1002/jnr.490280409 · Cited by 54 · see citing works

A kind of preclinic stage mice model of pakinson's disease

Hu, Z. (2007) · Zhonghua shenjing waike zazhi